Nianzhen Li

Papers

Total Citations

H-Index

About

Nianzhen Li is a leading figure in the development of high-throughput ion channel screening technologies, with a primary focus on microfluidic patch clamp systems. Her major contributions center on advancing automated platforms that dramatically improve the efficiency and reliability of drug discovery assays. Li’s seminal work on the IonFlux system, a microfluidic patch clamp device evaluated for human *Ether-à-go-go* Related Gene (hERG) channel physiology and pharmacology, has garnered 40 citations for its critical role in optimizing throughput and predictive accuracy in measuring membrane current changes. This innovation addresses the pharmaceutical industry’s urgent need to identify promising compounds while minimizing cardiac side effects. Additionally, her 2012 study on ion channel pharmacology under flow, which automates well-plate microfluidics for consistent and rapid data production, has been cited 29 times, underscoring its utility in high-throughput screening. Li’s achievements have positioned her as a key innovator in bridging microfluidics and electrophysiology, enabling safer and more efficient drug development. Her work continues to inspire researchers seeking to integrate automation into complex biological assays.